{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:02:45Z","timestamp":1789689765062,"version":"4.0.1"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Scientific Research at Al-Zaytoonah University of Jordan","award":["2023-2022\/17\/50"],"award-info":[{"award-number":["2023-2022\/17\/50"]}]},{"name":"Deanship of Scientific Research at Al-Zaytoonah University of Jordan","award":["2023-2022\/17\/50"],"award-info":[{"award-number":["2023-2022\/17\/50"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10899-2","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:53:32Z","timestamp":1744728812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-5425","authenticated-orcid":false,"given":"Rima","family":"Hajjo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama H.","family":"Abusara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima A.","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa K.","family":"Bardaweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"10899_CR1","unstructured":"CDC | About Mpox; available from: https:\/\/www.cdc.gov\/mpox\/about\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/poxvirus\/mpox\/about\/index.html. Accessed 10 Sept 2024."},{"key":"10899_CR2","unstructured":"WHO | WHO recommends new name for monkeypox disease; available from: https:\/\/www.who.int\/news\/item\/28-11-2022-who-recommends-new-name-for-monkeypox-disease. Accessed 10 Sept 2024."},{"issue":"12","key":"10899_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/v9120380","volume":"9","author":"MG Reynolds","year":"2017","unstructured":"Reynolds MG, McCollum AM, Nguete B, Shongo Lushima R, Petersen BW. Improving the Care and Treatment of Monkeypox Patients in Low\u2013Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research. Viruses. 2017;9(12):380.","journal-title":"Viruses."},{"key":"10899_CR4","unstructured":"WHO | Mpox; available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mpox. Accessed 10 Sept 2024."},{"issue":"7","key":"10899_CR5","first-page":"e26531","volume":"14","author":"J Kaler","year":"2022","unstructured":"Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation. Cureus. 2022;14(7):e26531.","journal-title":"Cureus"},{"issue":"1","key":"10899_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","volume":"8","author":"J Lu","year":"2023","unstructured":"Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, Yin L, Yang Y, Tan W, Shen L. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Target Ther. 2023;8(1):458.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10899_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s15010-022-01935-3","volume":"50","author":"M Shafaati","year":"2022","unstructured":"Shafaati M, Zandi M. State-of-the-art on monkeypox virus: an emerging zoonotic disease. Infection. 2022;50(6):1425\u20131430.","journal-title":"Infection"},{"key":"10899_CR8","doi-asserted-by":"crossref","unstructured":"N S, Kandi V, G SR, Ca J, A H, As A, Kapil C, Palacholla PS: Kyasanur Forest Disease: A Comprehensive Review. Cureus. 2024;16(7):e65228.","DOI":"10.7759\/cureus.65228"},{"key":"10899_CR9","doi-asserted-by":"publisher","first-page":"1149909","DOI":"10.3389\/fphar.2023.1149909","volume":"14","author":"MA Shamim","year":"2023","unstructured":"Shamim MA, Satapathy P, Padhi BK, Veeramachaneni SD, Akhtar N, Pradhan A, Agrawal A, Dwivedi P, Mohanty A, Pradhan KB, et al. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis. Front Pharmacol. 2023;14:1149909.","journal-title":"Front Pharmacol"},{"issue":"4","key":"10899_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","volume":"16","author":"A Karagoz","year":"2023","unstructured":"Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, Smajlovi\u0107 S, \u0106ordi\u0107 S, Rabaan AA, Alsuhaimi E. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023;16(4):531\u201341.","journal-title":"J Infect Public Health"},{"key":"10899_CR11","doi-asserted-by":"crossref","unstructured":"Rabaan AA, Abas AH, Tallei TE, Al-Zaher MA, Al-Sheef NM, Fatimawali, Al-Nass EZ, Al-Ebrahim EA, Effendi Y, Idroes R, et al: Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies. J Med Virol. 2023;95(1):e28306.","DOI":"10.1002\/jmv.28306"},{"key":"10899_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.18433\/jpps33138","volume":"25","author":"M Soheili","year":"2022","unstructured":"Soheili M, Nasseri S, Afraie M, Khateri S, Moradi Y, Mahdavi Mortazavi SM, Gilzad-Kohan H. Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments. J Pharm Pharm Sci. 2022;25:297\u2013322.","journal-title":"J Pharm Pharm Sci"},{"issue":"10","key":"10899_CR13","first-page":"1969","volume":"13","author":"G Bruno","year":"2023","unstructured":"Bruno G, Buccoliero GB. Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review. Life. Basel: 2023;13(10):1969.","journal-title":"Life (Basel, Switzerland)."},{"issue":"9","key":"10899_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and Treatment of Monkeypox. Drugs. 2022;82(9):957\u201363.","journal-title":"Drugs"},{"issue":"12","key":"10899_CR15","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3390\/vaccines10122091","volume":"10","author":"AA Saied","year":"2022","unstructured":"Saied AA, Dhawan M, Metwally AA, Fahrni ML, Choudhary P, Choudhary OP. Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review. Vaccines. 2022;10(12):2091.","journal-title":"Vaccines"},{"issue":"10","key":"10899_CR16","doi-asserted-by":"publisher","first-page":"e7666","DOI":"10.1371\/journal.pone.0007666","volume":"4","author":"GL Emerson","year":"2009","unstructured":"Emerson GL, Li Y, Frace MA, Olsen-Rasmussen MA, Khristova ML, Govil D, Sammons SA, Regnery RL, Karem KL, Damon IK, et al. The phylogenetics and ecology of the orthopoxviruses endemic to North America. PLoS ONE. 2009;4(10):e7666.","journal-title":"PLoS ONE"},{"issue":"21","key":"10899_CR17","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.3390\/jcm11216388","volume":"11","author":"F Scarpa","year":"2022","unstructured":"Scarpa F, Sanna D, Azzena I, Cossu P, Locci C, Angeletti S, Maruotti A, Ceccarelli G, Casu M, Fiori PL, et al. Genetic Variability of the Monkeypox Virus Clade IIb\u00a0B.1. J Clin Med. 2022;11(21):6388.","journal-title":"J Clin Med."},{"issue":"2","key":"10899_CR18","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141.","journal-title":"PLoS Negl Trop Dis"},{"key":"10899_CR19","doi-asserted-by":"publisher","first-page":"1029215","DOI":"10.3389\/fpubh.2023.1029215","volume":"11","author":"SA Meo","year":"2023","unstructured":"Meo SA, Al-Khlaiwi T, Al Jassir FF, Meo AS. Impact of traveling on transmission trends of human monkeypox disease: worldwide data based observational analysis. Front Public Health. 2023;11:1029215.","journal-title":"Front Public Health"},{"issue":"10","key":"10899_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.tips.2023.08.003","volume":"44","author":"G Andrei","year":"2023","unstructured":"Andrei G, Snoeck R. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Trends Pharmacol Sci. 2023;44(10):719\u201339.","journal-title":"Trends Pharmacol Sci"},{"key":"10899_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102855","volume":"131","author":"N Kumar","year":"2022","unstructured":"Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun. 2022;131:102855.","journal-title":"J Autoimmun"},{"issue":"7","key":"10899_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/pathogens12070947","volume":"12","author":"DE Mart\u00ednez-Fern\u00e1ndez","year":"2023","unstructured":"Mart\u00ednez-Fern\u00e1ndez DE, Fern\u00e1ndez-Quezada D, Casillas-Mu\u00f1oz FAG, Carrillo-Ballesteros FJ, Ortega-Prieto AM, Jimenez-Guarde\u00f1o JM, Regla-Nava JA. Human Monkeypox: A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies. Pathog. 2023;12(7):947.","journal-title":"Pathog"},{"issue":"1","key":"10899_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41392-022-01215-4","volume":"7","author":"Y Huang","year":"2022","unstructured":"Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduct Target Ther. 2022;7(1):373.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10899_CR24","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1016\/S1473-3099(24)00514-0","volume":"24","author":"DL Wannigama","year":"2024","unstructured":"Wannigama DL, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Besa JJV, Miyanaga K, Cui L, Fernandez S, Huang AT, et al. Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south. Lancet Infect Dis. 2024;24(10):e610\u20133.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10899_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJMc2210823","volume":"388","author":"M Viedma-Martinez","year":"2023","unstructured":"Viedma-Martinez M, Dominguez-Tosso FR, Jimenez-Gallo D, Garcia-Palacios J, Riera-Tur L, Montiel-Quezel N, Linares-Barrios M. MPXV Transmission at a Tattoo Parlor. N Engl J Med. 2023;388(1):92\u20134.","journal-title":"N Engl J Med"},{"issue":"8","key":"10899_CR26","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s11739-022-03090-x","volume":"17","author":"C Tascini","year":"2022","unstructured":"Tascini C, Geminiani M, Sbrana F, Pagotto A, Martini L. Possible tattoo-transmitted monkeypox viral infection. Intern Emerg Med. 2022;17(8):2421\u20132.","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10899_CR27","doi-asserted-by":"publisher","first-page":"e0136522","DOI":"10.1128\/jcm.01365-22","volume":"61","author":"V Gaspari","year":"2023","unstructured":"Gaspari V, Rossini G, Robuffo S, Rapparini L, Scagliarini A. Mistral De Pascali A, Piraccini BM, Lazzarotto T: Monkeypox Outbreak 2022: Clinical and Virological Features of 30 Patients at the Sexually Transmitted Diseases Centre of Sant\u2019 Orsola Hospital, Bologna, Northeastern Italy. J Clin Microbiol. 2023;61(1):e0136522.","journal-title":"J Clin Microbiol"},{"key":"10899_CR28","doi-asserted-by":"publisher","first-page":"1174223","DOI":"10.3389\/fimmu.2023.1174223","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Leng P, Zhou H. Global transmission of monkeypox virus-a potential threat under the COVID-19 pandemic. Front Immunol. 2023;14:1174223.","journal-title":"Front Immunol"},{"issue":"1","key":"10899_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43162-023-00233-0","volume":"35","author":"AA Saied","year":"2023","unstructured":"Saied AA, Chandran D, Chakraborty S, Emran TB, Dhama K. Mpox and healthcare workers \u2014 a minireview of our present knowledge. The Egyptian Journal of Internal Medicine. 2023;35(1):46.","journal-title":"The Egyptian Journal of Internal Medicine"},{"key":"10899_CR30","doi-asserted-by":"publisher","first-page":"106762","DOI":"10.1016\/j.ijsu.2022.106762","volume":"104","author":"AA Saied","year":"2022","unstructured":"Saied AA. Should not airborne transmission be ignored in the 2022 monkeypox outbreak? Int J Surg. 2022;104:106762.","journal-title":"Int J Surg"},{"issue":"5","key":"10899_CR31","doi-asserted-by":"publisher","first-page":"e28775","DOI":"10.1002\/jmv.28775","volume":"95","author":"AA Saied","year":"2023","unstructured":"Saied AA. Mpox virus Clade IIb detection in the air. J Med Virol. 2023;95(5):e28775.","journal-title":"J Med Virol"},{"issue":"12","key":"10899_CR32","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1016\/S2666-5247(22)00257-9","volume":"3","author":"S Gould","year":"2022","unstructured":"Gould S, Atkinson B, Onianwa O, Spencer A, Furneaux J, Grieves J, Taylor C, Milligan I, Bennett A, Fletcher T, et al. Air and surface sampling for monkeypox virus in a UK hospital: an observational study. Lancet Microbe. 2022;3(12):e904\u201311.","journal-title":"Lancet Microbe"},{"issue":"1","key":"10899_CR33","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2666-5247(22)00291-9","volume":"4","author":"B Hernaez","year":"2023","unstructured":"Hernaez B, Mu\u00f1oz-G\u00f3mez A, Sanchiz A, Orviz E, Valls-Carbo A, Sagastagoitia I, Ayerdi O, Mart\u00edn R, Puerta T, Vera M, et al. Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study. Lancet Microbe. 2023;4(1):e21\u20138.","journal-title":"Lancet Microbe"},{"issue":"2","key":"10899_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jviromet.2012.10.009","volume":"187","author":"D Verreault","year":"2013","unstructured":"Verreault D, Killeen SZ, Redmann RK, Roy CJ. Susceptibility of monkeypox virus aerosol suspensions in a rotating chamber. J Virol Methods. 2013;187(2):333\u20137.","journal-title":"J Virol Methods"},{"key":"10899_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fcimb.2012.00117","volume":"2","author":"RE Barnewall","year":"2012","unstructured":"Barnewall RE, Fisher DA, Robertson AB, Vales PA, Knostman KA, Bigger JE. Inhalational monkeypox virus infection in cynomolgus macaques. Front Cell Infect Microbiol. 2012;2:117.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10899_CR36","doi-asserted-by":"publisher","first-page":"e12880","DOI":"10.1371\/journal.pone.0012880","volume":"5","author":"A Nalca","year":"2010","unstructured":"Nalca A, Livingston VA, Garza NL, Zumbrun EE, Frick OM, Chapman JL, Hartings JM. Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus. PLoS One. 2010;5(9):e12880.","journal-title":"PLoS One."},{"issue":"12","key":"10899_CR37","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/labinvest.3780373","volume":"81","author":"GM Zaucha","year":"2001","unstructured":"Zaucha GM, Jahrling PB, Geisbert TW, Swearengen JR, Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest. 2001;81(12):1581\u2013600.","journal-title":"Lab Invest"},{"issue":"10353","key":"10899_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(22)01487-8","volume":"400","author":"S Seang","year":"2022","unstructured":"Seang S, Burrel S, Todesco E, Leducq V, Monsel G, Le Pluart D, Cordevant C, Pourcher V, Palich R. Evidence of human-to-dog transmission of monkeypox virus. The Lancet. 2022;400(10353):658\u20139.","journal-title":"The Lancet"},{"key":"10899_CR39","doi-asserted-by":"crossref","unstructured":"Choudhary OP, Priyanka, Chopra H, Shafaati M, Dhawan M, Metwally AA, Saied AA, Rabaan AA, Alhumaid S, Al Mutair A, et al. Reverse zoonosis and its relevance to the monkeypox outbreak 2022. New Microbes New Infect. 2022;49\u201350:101049.","DOI":"10.1016\/j.nmni.2022.101049"},{"issue":"2","key":"10899_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","volume":"46","author":"M Pv","year":"1959","unstructured":"Pv M. Andersen EK, Petersen KB, Birch-Andersen A: A POX-LIKE DISEASE IN CYNOMOLGUS MONKEYS. Acta Pathologica Microbiologica Scandinavica. 1959;46(2):156\u201376.","journal-title":"Acta Pathologica Microbiologica Scandinavica"},{"issue":"2","key":"10899_CR41","first-page":"165","volume":"58","author":"JG Breman","year":"1980","unstructured":"Breman JG, Kalisa R, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970\u201379. Bull World Health Organ. 1980;58(2):165\u201382.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10899_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","volume":"350","author":"KD Reed","year":"2004","unstructured":"Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, Kazmierczak JJ, Stratman EJ, Li Y, Fairley JA, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350(4):342\u201350.","journal-title":"N Engl J Med"},{"key":"10899_CR43","unstructured":"WHO | WHO Director-General's statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox - 23 July 2022; available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022. Accessed 13 Sept 2024."},{"key":"#cr-split#-10899_CR44.1","unstructured":"WHO | Fifth Meeting of the International Health Regulations (2005) (IHR) Emergency Committee on the Multi-Country Outbreak of mpox (monkeypox)"},{"key":"#cr-split#-10899_CR44.2","unstructured":"available from: https:\/\/www.who.int\/news\/item\/11-05-2023-fifth-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergency-committee-on-the-multi-country-outbreak-of-monkeypox-(mpox). Accessed 13 Sept 2024."},{"key":"10899_CR45","unstructured":"WHO | WHO Director-General declares mpox outbreak a public health emergency of international concern; available from: https:\/\/www.who.int\/news\/item\/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern. Accessed 10 Sept 2024)."},{"key":"10899_CR46","unstructured":"CDC | Mpox in the United States and Around the World: Current Situation Summary; available from: https:\/\/www.cdc.gov\/poxvirus\/mpox\/outbreak\/index.html. Accessed 10 Sept 2024."},{"key":"10899_CR47","unstructured":"WHO | 2022\u201324 Mpox (Monkeypox) Outbreak: Global Trends; available from: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/#34_Tables. Accessed 10 Sept 2024."},{"key":"10899_CR48","unstructured":"ICTV | Taxon Details: Orthopoxvirus monkeypox; available from: https:\/\/ictv.global\/taxonomy\/taxondetails?taxnode_id=202304771&taxon_name=Orthopoxvirus%20monkeypox. Accessed 10 Sept 2024."},{"key":"10899_CR49","unstructured":"NCBI |Genome assembly ViralProj15142; available from: https:\/\/www.ncbi.nlm.nih.gov\/datasets\/genome\/GCF_000857045.1\/. Accessed 19 Sept 2024."},{"key":"10899_CR50","unstructured":"ICTV | Genus: Orthopoxvirus; available from: https:\/\/ictv.global\/report\/chapter\/poxviridae\/poxviridae\/orthopoxvirus. Accessed 10 Sept 2024."},{"key":"10899_CR51","doi-asserted-by":"publisher","first-page":"125515","DOI":"10.1016\/j.ijbiomac.2023.125515","volume":"245","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang K, Zhou H. Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review. Int J Biol Macromol. 2023;245:125515.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"10899_CR52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/v15020568","volume":"15","author":"R Hajjo","year":"2023","unstructured":"Hajjo R, Sabbah DA, Abusara OH, Kharmah R, Bardaweel S. Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. Viruses. 2023;15(2):568.","journal-title":"Viruses"},{"issue":"1","key":"10899_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/mr.55.1.80-122.1991","volume":"55","author":"RM Buller","year":"1991","unstructured":"Buller RM, Palumbo GJ. Poxvirus pathogenesis. Microbiol Rev. 1991;55(1):80\u2013122.","journal-title":"Microbiol Rev"},{"issue":"2","key":"10899_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/sj.icb.7100033","volume":"85","author":"MM Stanford","year":"2007","unstructured":"Stanford MM, McFadden G, Karupiah G, Chaudhri G. Immunopathogenesis of poxvirus infections: forecasting the impending storm. Immunol Cell Biol. 2007;85(2):93\u2013102.","journal-title":"Immunol Cell Biol"},{"key":"10899_CR55","doi-asserted-by":"publisher","first-page":"198932","DOI":"10.1016\/j.virusres.2022.198932","volume":"322","author":"E Lansiaux","year":"2022","unstructured":"Lansiaux E, Jain N, Laivacuma S, Reinis A. The virology of human monkeypox virus (hMPXV): A brief overview. Virus Res. 2022;322:198932.","journal-title":"Virus Res"},{"issue":"7","key":"10899_CR56","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1091\/mbc.12.7.2031","volume":"12","author":"N Tolonen","year":"2001","unstructured":"Tolonen N, Doglio L, Schleich S, Krijnse Locker J. Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. Mol Biol Cell. 2001;12(7):2031\u201346.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10899_CR57","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/v4050688","volume":"4","author":"B Moss","year":"2012","unstructured":"Moss B. Poxvirus cell entry: how many proteins does it take? Viruses. 2012;4(5):688\u2013707.","journal-title":"Viruses"},{"issue":"4","key":"10899_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.virs.2022.07.006","volume":"37","author":"Q Gong","year":"2022","unstructured":"Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: a re-emergent threat to humans. Virol Sin. 2022;37(4):477\u201382.","journal-title":"Virol Sin"},{"key":"10899_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","volume":"60","author":"B Moss","year":"2016","unstructured":"Moss B. Membrane fusion during poxvirus entry. Semin Cell Dev Biol. 2016;60:89\u201396.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10899_CR60","doi-asserted-by":"publisher","first-page":"e0228028","DOI":"10.1371\/journal.pone.0228028","volume":"15","author":"Q Kieser","year":"2020","unstructured":"Kieser Q, Noyce RS, Shenouda M, Lin YJ, Evans DH. Cytoplasmic factories, virus assembly, and DNA replication kinetics collectively constrain the formation of poxvirus recombinants. PLoS ONE. 2020;15(1):e0228028.","journal-title":"PLoS ONE"},{"issue":"4","key":"10899_CR61","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","volume":"33","author":"E Petersen","year":"2019","unstructured":"Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A. Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019;33(4):1027\u201343.","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10899_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","volume":"340","author":"N Chen","year":"2005","unstructured":"Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, Feng Z, Schriewer J, Buck C, Wang C, Lefkowitz EJ, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology. 2005;340(1):46\u201363.","journal-title":"Virology"},{"key":"10899_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-0716-3239-0_12","volume":"2673","author":"L Ballesteros-Sanabria","year":"2023","unstructured":"Ballesteros-Sanabria L, Pelaez-Prestel HF, Reche PA, Lafuente EM. EPIPOX: A Resource Facilitating Epitope-Vaccine Design Against Human Pathogenic Orthopoxviruses. Methods Mol Biol. 2023;2673:175\u201385.","journal-title":"Methods Mol Biol"},{"key":"10899_CR64","unstructured":"BV-BRC | Viruses: Genomes; available from: https:\/\/www.bv-brc.org\/view\/Taxonomy\/10244. Accessed 19 Sept 2024."},{"key":"10899_CR65","unstructured":"NCBI | Genome: Monkeypox virus; available from: https:\/\/www.ncbi.nlm.nih.gov\/datasets\/genome\/?taxon=10244. Accessed 19 Sept 2024."},{"issue":"1","key":"10899_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health. Glob Chall. 2017;1(1):33\u201346.","journal-title":"Glob Chall"},{"key":"10899_CR67","unstructured":"GISAID | GISAID Database; available from: https:\/\/gisaid.org\/. Accessed 23 Sept 2024."},{"key":"10899_CR68","doi-asserted-by":"crossref","unstructured":"Americo JL, Earl PL, Moss B: Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci U S A. 2023;120(8):e2220415120.","DOI":"10.1073\/pnas.2220415120"},{"key":"10899_CR69","unstructured":"GISAID | Tracking of Mpox Variants: Clade Ib; available from: https:\/\/gisaid.org\/mpox-variants\/. Accessed 15 Sept 2024."},{"key":"10899_CR70","unstructured":"Moore MJ, Rathish B, Zahra F: Mpox (Monkeypox). In: StatPearls. edn. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"issue":"11","key":"10899_CR71","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/v12111257","volume":"12","author":"E Alakunle","year":"2020","unstructured":"Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses. 2020;12(11):1257.","journal-title":"Viruses."},{"issue":"2","key":"10899_CR72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1001\/jama.2022.10259","volume":"328","author":"K Walter","year":"2022","unstructured":"Walter K, Malani PN. What Is Monkeypox? JAMA. 2022;328(2):222.","journal-title":"JAMA"},{"issue":"7","key":"10899_CR73","first-page":"e26756","volume":"14","author":"AY Cheema","year":"2022","unstructured":"Cheema AY, Ogedegbe OJ, Munir M, Alugba G, Ojo TK. Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2022;14(7):e26756.","journal-title":"Cureus"},{"key":"10899_CR74","doi-asserted-by":"crossref","unstructured":"Pittman PR, Martin JW, Kingebeni PM, Tamfum J-JM, Wan Q, Reynolds MG, Quinn X, Norris S, Townsend MB, Satheshkumar PS, et al. Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo. medRxiv. 2022:2022.2005.2026.22273379.","DOI":"10.1101\/2022.05.26.22273379"},{"issue":"1","key":"10899_CR75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12941-022-00527-1","volume":"21","author":"VA Benites-Zapata","year":"2022","unstructured":"Benites-Zapata VA, Ulloque-Badaracco JR, Alarcon-Braga EA, Hernandez-Bustamante EA, Mosquera-Rojas MD, Bonilla-Aldana DK, Rodriguez-Morales AJ. Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2022;21(1):36.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"10899_CR76","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/vaccines11081345","volume":"11","author":"S Malik","year":"2023","unstructured":"Malik S, Ahmed A, Ahsan O, Muhammad K, Waheed Y. Monkeypox Virus: A Comprehensive Overview of Viral Pathology, Immune Response, and Antiviral Strategies. Vaccines (Basel). 2023;11(8):1345.","journal-title":"Vaccines (Basel)."},{"issue":"2","key":"10899_CR77","doi-asserted-by":"publisher","first-page":"e28560","DOI":"10.1002\/jmv.28560","volume":"95","author":"G Ciccarese","year":"2023","unstructured":"Ciccarese G, Di Biagio A, Bruzzone B, Guadagno A, Taramasso L, Oddenino G, Brucci G, Labate L, De Pace V, Mastrolonardo M, et al. Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients. J Med Virol. 2023;95(2):e28560.","journal-title":"J Med Virol"},{"issue":"10","key":"10899_CR78","first-page":"685","volume":"50","author":"JM Wick","year":"2023","unstructured":"Wick JM, Pelliccione A, Lee-Rodriguez C, Tran HN, McCleskey PE, Nichol A, Skarbinski J. An Atypical Presentation of Mpox Transmitted Between Transgender Men Through Oral Sex. Sex Transm Dis. 2023;50(10):685\u20136.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10899_CR79","first-page":"770","volume":"116","author":"N Elsheikh","year":"2023","unstructured":"Elsheikh N, Salvia Milos A. Atypical Clinical presentation of a patient with Monkeypox. Ir Med J. 2023;116(5):770.","journal-title":"Ir Med J"},{"issue":"12","key":"10899_CR80","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1080\/23744235.2022.2121420","volume":"54","author":"\u00d3G P\u00e9rez-Mart\u00edn","year":"2022","unstructured":"P\u00e9rez-Mart\u00edn \u00d3G, Hern\u00e1ndez-Aceituno A, Dorta-Espi\u00f1eira MM, Garc\u00eda-Hern\u00e1ndez L, Larumbe-Zabala E. Atypical presentation of sexually-transmitted monkeypox lesions. Infect Dis (Lond). 2022;54(12):940\u20133.","journal-title":"Infect Dis (Lond)"},{"issue":"5","key":"10899_CR81","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.eimc.2022.09.003","volume":"41","author":"JV Frade","year":"2023","unstructured":"Frade JV, Sousa I, Marques T, Filipe P. Acute paronychia: An atypical presentation of Monkeypox infection. Enferm Infecc Microbiol Clin. 2023;41(5):317\u20138.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10899_CR82","doi-asserted-by":"publisher","first-page":"1106247","DOI":"10.3389\/fmicb.2023.1106247","volume":"14","author":"M Zandi","year":"2023","unstructured":"Zandi M, Shafaati M, Hosseini F. Mechanisms of immune evasion of monkeypox virus. Front Microbiol. 2023;14:1106247.","journal-title":"Front Microbiol"},{"key":"10899_CR83","doi-asserted-by":"publisher","first-page":"104424","DOI":"10.1016\/j.ebiom.2022.104424","volume":"87","author":"H Li","year":"2023","unstructured":"Li H, Huang QZ, Zhang H, Liu ZX, Chen XH, Ye LL, Luo Y. The land-scape of immune response to monkeypox virus. EBioMedicine. 2023;87:104424.","journal-title":"EBioMedicine"},{"issue":"7","key":"10899_CR84","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/biomedicines9070765","volume":"9","author":"H Yu","year":"2021","unstructured":"Yu H, Bruneau RC, Brennan G, Rothenburg S. Battle Royale: Innate Recognition of Poxviruses and Viral Immune Evasion. Biomedicines. 2021;9(7):765.","journal-title":"Biomedicines"},{"key":"10899_CR85","unstructured":"Clarivate | Metacore - Integrated pathway analysis for multi-OMICs data; https:\/\/clarivate.com\/life-sciences-healthcare\/webinars\/metacore-integrated-pathway-analysis-for-multi-omics-data\/. Accessed 10 Sept 2024."},{"issue":"11","key":"10899_CR86","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"key":"10899_CR87","doi-asserted-by":"crossref","unstructured":"Reis T, de Assis Rocha Neves F, Fagundes A, Jr., See E, da Hora Passos R, Zawadzki B, Bellomo R, Ronco C: Monkeypox-Associated Acute Kidney Injury and Foreseeable Impacts on Nephrology and Kidney Transplantation Services. Blood Purification .2023;52(4):319\u2013322.","DOI":"10.1159\/000528041"},{"issue":"6","key":"10899_CR88","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.chom.2023.05.001","volume":"31","author":"M Hubert","year":"2023","unstructured":"Hubert M, Guivel-Benhassine F, Bruel T, Porrot F, Planas D, Vanhomwegen J, Wiedemann A, Burrel S, Marot S, Palich R, et al. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals. Cell Host Microbe. 2023;31(6):937-948.e934.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10899_CR89","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.virol.2004.03.012","volume":"324","author":"JO Langland","year":"2004","unstructured":"Langland JO, Jacobs BL. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology. 2004;324(2):419\u201329.","journal-title":"Virology"},{"issue":"7","key":"10899_CR90","first-page":"867","volume":"12","author":"KL Karem","year":"2005","unstructured":"Karem KL, Reynolds M, Braden Z, Lou G, Bernard N, Patton J, Damon IK. characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol. 2005;12(7):867\u201372.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10899_CR91","doi-asserted-by":"publisher","first-page":"e28429","DOI":"10.1002\/jmv.28429","volume":"95","author":"CK Lim","year":"2023","unstructured":"Lim CK, Roberts J, Moso M, Liew KC, Taouk ML, Williams E, Tran T, Steinig E, Caly L, Williamson DA. Mpox diagnostics: Review of current and emerging technologies. J Med Virol. 2023;95(1):e28429.","journal-title":"J Med Virol"},{"issue":"11","key":"10899_CR92","doi-asserted-by":"publisher","first-page":"e00011","DOI":"10.1128\/JVI.00011-17","volume":"91","author":"S Realegeno","year":"2017","unstructured":"Realegeno S, Puschnik AS, Kumar A, Goldsmith C, Burgado J, Sambhara S, Olson VA, Carroll D, Damon I, Hirata T, et al. Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation. J Virol. 2017;91(11):e00011-17.","journal-title":"J Virol."},{"issue":"3","key":"10899_CR93","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3181\/00379727-139-36266","volume":"139","author":"CT Cho","year":"1972","unstructured":"Cho CT, Wenner HA. In vitro growth characteristics of monkeypox virus. Proc Soc Exp Biol Med. 1972;139(3):916\u201320.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10899_CR94","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3201\/eid0604.000427","volume":"6","author":"HR Gelderblom","year":"2000","unstructured":"Gelderblom HR, Hazelton PR. Specimen collection for electron microscopy. Emerg Infect Dis. 2000;6(4):433\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10899_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0303-6987.2005.00254.x","volume":"32","author":"IB Bayer-Garner","year":"2005","unstructured":"Bayer-Garner IB. Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings. J Cutan Pathol. 2005;32(1):28\u201334.","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10899_CR96","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0035-9203(85)90333-5","volume":"79","author":"MJ Stagles","year":"1985","unstructured":"Stagles MJ, Watson AA, Boyd JF, More IA, McSeveney D. The histopathology and electron microscopy of a human monkeypox lesion. Trans R Soc Trop Med Hyg. 1985;79(2):192\u2013202.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10899_CR97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jmv.1890010107","volume":"1","author":"JJ Esposito","year":"1977","unstructured":"Esposito JJ, Obijeski JF, Nakano JH. Serological relatedness of monkeypox, variola, and vaccinia viruses. J Med Virol. 1977;1(1):35\u201347.","journal-title":"J Med Virol"},{"issue":"12","key":"10899_CR98","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1086\/498155","volume":"41","author":"A Nalca","year":"2005","unstructured":"Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005;41(12):1765\u201371.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10899_CR99","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/BF01251021","volume":"44","author":"R Gispen","year":"1974","unstructured":"Gispen R, Huisman J, Brand-Saathof B, Hekker AC. Immunofluorescence test for persistent poxvirus antibodies. Arch Gesamte Virusforsch. 1974;44(4):391\u20135.","journal-title":"Arch Gesamte Virusforsch"},{"issue":"9","key":"10899_CR100","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1273","volume":"11","author":"E Hammarlund","year":"2005","unstructured":"Hammarlund E, Lewis MW, Carter SV, Amanna I, Hansen SG, Strelow LI, Wong SW, Yoshihara P, Hanifin JM, Slifka MK. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005;11(9):1005\u201311.","journal-title":"Nat Med"},{"issue":"5","key":"10899_CR101","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/vbz.2011.0779","volume":"12","author":"ME Dubois","year":"2012","unstructured":"Dubois ME, Hammarlund E, Slifka MK. Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection. Vector Borne Zoonotic Dis. 2012;12(5):400\u20139.","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10899_CR102","first-page":"31","volume":"90","author":"Z Jezek","year":"1987","unstructured":"Jezek Z, Nakano JH, Arita I, Mutombo M, Szczeniowski M, Dunn C. Serological survey for human monkeypox infections in a selected population in Zaire. J Trop Med Hyg. 1987;90(1):31\u20138.","journal-title":"J Trop Med Hyg"},{"issue":"4","key":"10899_CR103","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3201\/eid1404.071044","volume":"14","author":"ME Dubois","year":"2008","unstructured":"Dubois ME, Slifka MK. Retrospective analysis of monkeypox infection. Emerg Infect Dis. 2008;14(4):592\u20139.","journal-title":"Emerg Infect Dis"},{"key":"10899_CR104","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1743-422X-8-139","volume":"8","author":"M Kramski","year":"2011","unstructured":"Kramski M, Drozd A, Lichtfuss GF, Dabrowski PW, Ellerbrok H. Rapid detection of anti-Vaccinia virus neutralizing antibodies. Virol J. 2011;8:139.","journal-title":"Virol J"},{"issue":"2","key":"10899_CR105","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jmv.1890010203","volume":"1","author":"JJ Esposito","year":"1977","unstructured":"Esposito JJ, Obijeski JF, Nakano JH. The virion and soluble antigen proteins of variola, monkeypox, and vaccinia viruses. J Med Virol. 1977;1(2):95\u2013110.","journal-title":"J Med Virol"},{"issue":"2","key":"10899_CR106","doi-asserted-by":"publisher","first-page":"e55488","DOI":"10.1371\/journal.pone.0055488","volume":"8","author":"CL Hutson","year":"2013","unstructured":"Hutson CL, Gallardo-Romero N, Carroll DS, Clemmons C, Salzer JS, Nagy T, Hughes CM, Olson VA, Karem KL, Damon IK. Transmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge system. PLoS ONE. 2013;8(2):e55488.","journal-title":"PLoS ONE"},{"key":"10899_CR107","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez de Marco Mdel M, Alejo A, Hudson P, Damon IK, Alcami A: The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. Faseb J. 2010;24(5):1479\u20131488.","DOI":"10.1096\/fj.09-144733"},{"issue":"Pt 2","key":"10899_CR108","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1099\/0022-1317-58-2-251","volume":"58","author":"D Baxby","year":"1982","unstructured":"Baxby D. The surface antigens of orthopoxviruses detected by cross-neutralization tests on cross-absorbed antisera. J Gen Virol. 1982;58(Pt 2):251\u201362.","journal-title":"J Gen Virol"},{"issue":"2","key":"10899_CR109","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","volume":"58","author":"AM McCollum","year":"2014","unstructured":"McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58(2):260\u20137.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10899_CR110","doi-asserted-by":"publisher","first-page":"e79953","DOI":"10.1371\/journal.pone.0079953","volume":"8","author":"PW Dabrowski","year":"2013","unstructured":"Dabrowski PW, Radoni\u0107 A, Kurth A, Nitsche A. Genome-wide comparison of cowpox viruses reveals a new clade related to Variola virus. PLoS ONE. 2013;8(12):e79953.","journal-title":"PLoS ONE"},{"issue":"32","key":"10899_CR111","doi-asserted-by":"publisher","first-page":"2200497","DOI":"10.2807\/1560-7917.ES.2022.27.32.2200497","volume":"27","author":"JF Huggett","year":"2022","unstructured":"Huggett JF, French D, O\u2019Sullivan DM, Moran-Gilad J, Zumla A. Monkeypox: another test for PCR. Euro Surveill. 2022;27(32):2200497.","journal-title":"Euro Surveill."},{"key":"10899_CR112","unstructured":"WHO | Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022. available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-laboratory-2022.1. Accessed 10 Sept 2024."},{"issue":"6","key":"10899_CR113","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/jmv.21494","volume":"81","author":"I Iizuka","year":"2009","unstructured":"Iizuka I, Saijo M, Shiota T, Ami Y, Suzaki Y, Nagata N, Hasegawa H, Sakai K, Fukushi S, Mizutani T, et al. Loop-mediated isothermal amplification-based diagnostic assay for monkeypox virus infections. J Med Virol. 2009;81(6):1102\u20138.","journal-title":"J Med Virol"},{"issue":"7","key":"10899_CR114","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1371\/journal.pbio.0040204","volume":"4","author":"O Piepenburg","year":"2006","unstructured":"Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLoS Biol. 2006;4(7):e204.","journal-title":"PLoS Biol"},{"issue":"6","key":"10899_CR115","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/10409238.2021.1937927","volume":"56","author":"J Gl\u00f6kler","year":"2021","unstructured":"Gl\u00f6kler J, Lim TS, Ida J, Frohme M. Isothermal amplifications - a comprehensive review on current methods. Crit Rev Biochem Mol Biol. 2021;56(6):543\u201386.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10899_CR116","doi-asserted-by":"crossref","unstructured":"Zhao F, Wang P, Wang H, Liu S, Sohail M, Zhang X, Li B, Huang H: CRISPR\/Cas12a-mediated ultrasensitive and on-site monkeypox viral testing. medRxiv. 2022:2022.2010.2010.22280931.","DOI":"10.1101\/2022.10.10.22280931"},{"issue":"6","key":"10899_CR117","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jiph.2023.04.001","volume":"16","author":"F Amer","year":"2023","unstructured":"Amer F, Khalil HES, Elahmady M, ElBadawy NE, Zahran WA, Abdelnasser M, Rodr\u00edguez-Morales AJ, Wegdan AA, Tash RME. Mpox: Risks and approaches to prevention. J Infect Public Health. 2023;16(6):901\u201310.","journal-title":"J Infect Public Health"},{"key":"10899_CR118","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.2147\/PPA.S436622","volume":"17","author":"W Al-Qerem","year":"2023","unstructured":"Al-Qerem W, Alassi A, Jarab A, Al Bawab AQ, Hammad A, Alasmari F, Alazab B, Abu Husein D, Al Momani N, Eberhardt J. Examining Influenza Vaccination Patterns Among Young Adults with Asthma: Insights into Knowledge, Attitudes, and Practices. Patient Prefer Adherence. 2023;17:2899\u2013913.","journal-title":"Patient Prefer Adherence"},{"key":"10899_CR119","unstructured":"CDC | Vaccine-Preventable Diseases; available from: https:\/\/www.cdc.gov\/global-immunization\/diseases\/index.html. Accessed 14 Sept 2024."},{"key":"10899_CR120","unstructured":"CDC | Mpox-Vaccination; available from: https:\/\/www.cdc.gov\/poxvirus\/mpox\/interim-considerations\/overview.html#:~:text=Resources-,Vaccines,to%20orthopoxvirus%20infections%2C%20including%20mpox. Accessed 14 Sept 2024."},{"key":"10899_CR121","unstructured":"WHO | Vaccine-Preventable Diseases (including pipeline vaccines); available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases. Accessed 14 Sept 2024."},{"issue":"1","key":"10899_CR122","doi-asserted-by":"publisher","first-page":"2977631","DOI":"10.1155\/adph\/2977631","volume":"2024","author":"R Hajjo","year":"2024","unstructured":"Hajjo R, Sabbah DA, Bardaweel SK, Abusara OH. Epidemiology Analysis of COVID-19 Data and Associated Effects of Pandemic Containment Procedures, Viral Variants, and Vaccines: Lessons Learned From Middle Eastern Jordan\u2019s Experience. Advances in Public Health. 2024;2024(1):2977631.","journal-title":"Advances in Public Health"},{"issue":"11","key":"10899_CR123","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/vaccines11111708","volume":"11","author":"RM Ghazy","year":"2023","unstructured":"Ghazy RM, Elrewany E, Gebreal A, ElMakhzangy R, Fadl N, Elbanna EH, Tolba MM, Hammad EM, Youssef N, Abosheaishaa H, et al. Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine. Vaccines (Basel). 2023;11(11):1708.","journal-title":"Vaccines (Basel)."},{"key":"10899_CR124","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","volume":"97","author":"A Volz","year":"2017","unstructured":"Volz A, Sutter G. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development. Adv Virus Res. 2017;97:187\u2013243.","journal-title":"Adv Virus Res"},{"issue":"19","key":"10899_CR125","doi-asserted-by":"publisher","first-page":"17209","DOI":"10.1074\/jbc.M110920200","volume":"277","author":"RM Geha","year":"2002","unstructured":"Geha RM, Chen K, Wouters J, Ooms F, Shih JC. Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling. J Biol Chem. 2002;277(19):17209\u201316.","journal-title":"J Biol Chem"},{"issue":"15","key":"10899_CR126","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1021\/bi051847g","volume":"45","author":"M Li","year":"2006","unstructured":"Li M, Binda C, Mattevi A, Edmondson DE. Functional role of the \u201caromatic cage\u201d in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins. Biochemistry. 2006;45(15):4775\u201384.","journal-title":"Biochemistry"},{"key":"10899_CR127","doi-asserted-by":"crossref","unstructured":"Malone SM, Mitra AK, Onumah NA, Brown A, Jones LM, Tresvant D, Brown CS, Onyia AU, Iseguede FO: Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis. Int J Environ Res Public Health. 2023;20(4).","DOI":"10.3390\/ijerph20042963"},{"issue":"9","key":"10899_CR128","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S1473-3099(23)00270-0","volume":"23","author":"SN Ladhani","year":"2023","unstructured":"Ladhani SN, Dowell AC, Jones S, Hicks B, Rowe C, Begum J, Wailblinger D, Wright J, Owens S, Pickering A, et al. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response. Lancet Infect Dis. 2023;23(9):1042\u201350.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10899_CR129","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1111\/bcp.15830","volume":"89","author":"M van der Boom","year":"2023","unstructured":"van der Boom M, van Hunsel F. Adverse reactions following MPox (monkeypox) vaccination: An overview from the Dutch and global adverse event reporting systems. Br J Clin Pharmacol. 2023;89(11):3302\u20133310.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10899_CR130","doi-asserted-by":"publisher","first-page":"2242219","DOI":"10.1080\/21645515.2023.2242219","volume":"19","author":"N Tomita","year":"2023","unstructured":"Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Iwasaki H, Yano R, Suzuki T, Saito S, Okumura N, Sugiura W, et al. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox. Hum Vaccin Immunother. 2023;19(2):2242219.","journal-title":"Hum Vaccin Immunother"},{"key":"10899_CR131","doi-asserted-by":"publisher","first-page":"102407","DOI":"10.1016\/j.eclinm.2023.102407","volume":"68","author":"YC Lin","year":"2024","unstructured":"Lin YC, Wen TH, Shih WL, Vermund SH, Fang CT. Impact of vaccination and high-risk group awareness on the mpox epidemic in the United States, 2022\u20132023: a modelling study. EClinicalMedicine. 2024;68:102407.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10899_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278957","volume":"19","author":"J Bourner","year":"2024","unstructured":"Bourner J, Redji Mbrenga FD, Malaka CN, Dunning J, Rojek A, Fandema E, Horby P, Boum Y 2nd, Nakoun\u00e9 E, Olliaro P. Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme. PLoS ONE. 2024;19(5): e0278957.","journal-title":"PLoS ONE"},{"key":"10899_CR133","doi-asserted-by":"crossref","unstructured":"Matias WR, Koshy JM, Nagami EH, Kovac V, Moeng LR, Shenoy ES, Hooper DC, Madoff LC, Barshak MB, Johnson JA, et al. Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States.Open forum infectious diseases. 2022;9(8):ofac377.","DOI":"10.1093\/ofid\/ofac377"},{"issue":"13","key":"10899_CR134","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/jama.2022.15336","volume":"328","author":"AN Desai","year":"2022","unstructured":"Desai AN, Thompson GR 3rd, Neumeister SM, Arutyunova AM, Trigg K, Cohen SH. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. JAMA. 2022;328(13):1348\u201350.","journal-title":"JAMA"},{"issue":"37","key":"10899_CR135","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.15585\/mmwr.mm7137e1","volume":"71","author":"K O'Laughlin","year":"2022","unstructured":"O\u2019Laughlin K, Tobolowsky FA, Elmor R, Overton R, O\u2019Connor SM, Damon IK, Petersen BW, Rao AK, Chatham-Stephens K, Yu P, et al. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(37):1190\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10899_CR136","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/OLQ.0000000000001747","volume":"50","author":"EL Wu","year":"2023","unstructured":"Wu EL, Osborn RL, Bertram CM, Moore WJ, Galvin SR, Bolon MK, Masters MC, Krueger KM. Tecovirimat Use in Ambulatory and Hospitalized Patients With Monkeypox Virus Infection. Sex Transm Dis. 2023;50(3):172\u20134.","journal-title":"Sex Transm Dis"},{"key":"10899_CR137","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.antiviral.2017.01.009","volume":"143","author":"G Chittick","year":"2017","unstructured":"Chittick G, Morrison M, Brundage T, Nichols WG. Short-term clinical safety profile of brincidofovir: A favorable benefit\u2013risk proposition in the treatment of smallpox. Antiviral Res. 2017;143:269\u201377.","journal-title":"Antiviral Res"},{"key":"10899_CR138","doi-asserted-by":"crossref","unstructured":"Chan-Tack K, Harrington P, Bensman T, Choi S-Y, Donaldson E, O'Rear J, McMillan D, Myers L, Seaton M, Ghantous H, et al. Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation. Antiviral Res. 2021;195:105182.","DOI":"10.1016\/j.antiviral.2021.105182"},{"key":"10899_CR139","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/fmb-2019-0288","volume":"15","author":"JJ Alvarez-Cardona","year":"2020","unstructured":"Alvarez-Cardona JJ, Whited LK, Chemaly RF. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future Microbiol. 2020;15:389\u2013400.","journal-title":"Future Microbiol"},{"issue":"1","key":"10899_CR140","doi-asserted-by":"publisher","first-page":"e01925","DOI":"10.1128\/AAC.01925-18","volume":"63","author":"JM Chamberlain","year":"2019","unstructured":"Chamberlain JM, Sortino K, Sethna P, Bae A, Lanier R, Bambara RA, Dewhurst S. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus. Antimicrob Agents Chemother. 2019;63(1):e01925-e1918.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10899_CR141","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","volume":"57","author":"RO Baker","year":"2003","unstructured":"Baker RO, Bray M, Huggins JW. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003;57(1):13\u201323.","journal-title":"Antiviral Res"},{"issue":"3","key":"10899_CR142","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/095632020801900302","volume":"19","author":"DF Smee","year":"2008","unstructured":"Smee DF. Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal Models. Antivir Chem Chemother. 2008;19(3):115\u201324.","journal-title":"Antivir Chem Chemother"},{"issue":"1","key":"10899_CR143","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/v3010047","volume":"3","author":"AD Rice","year":"2011","unstructured":"Rice AD, Adams MM, Wallace G, Burrage AM, Lindsey SF, Smith AJ, Swetnam D, Manning BR, Gray SA, Lampert B, et al. Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans. Viruses. 2011;3(1):47\u201362.","journal-title":"Viruses"},{"issue":"1","key":"10899_CR144","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.antiviral.2012.02.005","volume":"94","author":"S Parker","year":"2012","unstructured":"Parker S, Chen NG, Foster S, Hartzler H, Hembrador E, Hruby D, Jordan R, Lanier R, Painter G, Painter W, et al. Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox \u2013 An animal model of smallpox. Antiviral Res. 2012;94(1):44\u201353.","journal-title":"Antiviral Res"},{"key":"10899_CR145","unstructured":"ClinicalTrials.gov. Identifier: NCT04706923. A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection (ATHENA); available from: https:\/\/www.clinicaltrials.gov\/study\/NCT04706923. Accessed 31 Oct 2024."},{"key":"10899_CR146","unstructured":"ClinicalTrials.gov. Identifier: NCT01143181. Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses; available from: https:\/\/clinicaltrials.gov\/study\/NCT01143181. Accessed 31 Oct 2024."},{"issue":"8","key":"10899_CR147","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ijd.14079","volume":"57","author":"AK Guzman","year":"2018","unstructured":"Guzman AK, Schairer DO, Garelik JL, Cohen SR. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial. Int J Dermatol. 2018;57(8):1001\u20136.","journal-title":"Int J Dermatol"},{"issue":"1","key":"10899_CR148","doi-asserted-by":"publisher","first-page":"e29354","DOI":"10.1002\/jmv.29354","volume":"96","author":"J Cinatl","year":"2024","unstructured":"Cinatl J, Bechtel M, Reus P, Ott M, Rothweiler F, Michaelis M, Ciesek S, Bojkova D. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models. J Med Virol. 2024;96(1):e29354.","journal-title":"J Med Virol"},{"key":"10899_CR149","doi-asserted-by":"publisher","first-page":"101779","DOI":"10.1016\/j.ajoc.2022.101779","volume":"29","author":"B Perzia","year":"2023","unstructured":"Perzia B, Theotoka D, Li K, Moss E, Matesva M, Gill M, Kibe M, Chow J, Green S. Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak. American journal of ophthalmology case reports. 2023;29:101779.","journal-title":"American journal of ophthalmology case reports"},{"issue":"1","key":"10899_CR150","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jamaophthalmol.2022.4567","volume":"141","author":"AR Kaufman","year":"2023","unstructured":"Kaufman AR, Chodosh J, Pineda R II. Monkeypox Virus and Ophthalmology\u2014A Primer on the 2022 Monkeypox Outbreak and Monkeypox-Related Ophthalmic Disease. JAMA Ophthalmol. 2023;141(1):78\u201383.","journal-title":"JAMA Ophthalmol"},{"key":"10899_CR151","unstructured":"Clarivate | Cortellis Drug Discovery Intelligence (CDDI); available from: https:\/\/clarivate.com\/products\/biopharma\/research-development\/pre-clinical-intelligence-analytics\/. Accessed 21 Sept 2024."},{"issue":"12","key":"10899_CR152","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/v15122360","volume":"15","author":"BM Ward","year":"2023","unstructured":"Ward BM, Riccio DA, Cartwright M, Maeda-Chubachi T. The Antiviral Effect of Berdazimer Sodium on Molluscum Contagiosum Virus Using a Novel In Vitro Methodology. Viruses. 2023;15(12):2360.","journal-title":"Viruses"},{"key":"10899_CR153","doi-asserted-by":"publisher","first-page":"100061","DOI":"10.1016\/j.glmedi.2024.100061","volume":"2","author":"G Olatunji","year":"2024","unstructured":"Olatunji G, Kokori E, Kwape JM, Fawehinmi P, Stanley AC, Oluwatobiloba AM, Abraham IC, Shimelis KM, Olafimihan A, Ezeano C, et al. Berdazimer: A novel nitric oxide therapy in treating molluscum contagiosum. J Med Surg Public Health. 2024;2:100061.","journal-title":"J Med Surg Public Health"},{"key":"10899_CR154","doi-asserted-by":"crossref","unstructured":"Remon J, Steuer CE, Ramalingam SS, Felip E: Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Ann Oncol. 2018;29(suppl_1):i20-i27.","DOI":"10.1093\/annonc\/mdx704"},{"issue":"1","key":"10899_CR155","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13555-015-0091-4","volume":"6","author":"K Capriotti","year":"2016","unstructured":"Capriotti K, Stewart K, Pelletier J, Capriotti J. Molluscum Contagiosum Viral Infection Treated With a Dilute Povidone-Iodine\/Dimethylsulfoxide Preparation. Dermatol Ther. 2016;6(1):101\u20133.","journal-title":"Dermatol Ther"},{"issue":"5","key":"10899_CR156","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1128\/JCM.05106-11","volume":"50","author":"J Tarrand Jeffrey","year":"2020","unstructured":"Tarrand Jeffrey J, LaSala PR, Han X-Y, Rolston Kenneth V, Kontoyiannis Dimitrios P. Dimethyl Sulfoxide Enhances Effectiveness of Skin Antiseptics and Reduces Contamination Rates of Blood Cultures. J Clin Microbiol. 2020;50(5):1552\u20137.","journal-title":"J Clin Microbiol"},{"key":"10899_CR157","unstructured":"NCIthesaurus| East Indian Sandalwood Oil Cream (Code C150380); available from: https:\/\/ncit.nci.nih.gov\/ncitbrowser\/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C150380. Accessed 6 Dec 2024."},{"key":"10899_CR158","unstructured":"AdisInsight| Santalum album cream - Santalis Healthcare; available from: https:\/\/adisinsight.springer.com\/drugs\/800033062. Accessed 6 Dec 2024."},{"issue":"6","key":"10899_CR159","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani A, Dulberger CL, De Silva NS, Marquette M, Lu YJ, Palowitch GM, Dokic A, Sanchez-Velazquez R, Schlatterer K, Sarkar S, et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell. 2024;187(6):1363-1373.e1312.","journal-title":"Cell"},{"key":"10899_CR160","unstructured":"ClinicalTrial.gov| A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines; available from: https:\/\/clinicaltrials.gov\/study\/NCT05988203. Accessed 6 Dec 2024."},{"key":"10899_CR161","unstructured":"PR-Newswire | Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients; available from: https:\/\/www.prnewswire.com\/news-releases\/ascletis-announces-fda-clearance-of-oral-rdrp-inhibitor-asc10-to-conduct-a-randomized-placebo-controlled-phase-ib-study-in-mild-to-moderate-covid-19-patients-301598784.html. Accessed 15 Sept 2024."},{"key":"10899_CR162","unstructured":"PR-Newswire | Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19; available from: https:\/\/www.prnewswire.com\/news-releases\/ascletis-announces-positive-phase-i-clinical-results-of-oral-rdrp-inhibitor-asc10-for-covid-19-301700402.html. Accessed 15 Sept 2024."},{"issue":"3","key":"10899_CR163","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3934\/microbiol.2023024","volume":"9","author":"A Chakraborty","year":"2023","unstructured":"Chakraborty A, Diwan A, Tatake J. Prospect of nanomaterials as antimicrobial and antiviral regimen. AIMS microbiology. 2023;9(3):444\u201366.","journal-title":"AIMS microbiology"},{"key":"10899_CR164","unstructured":"ContagionLive | A Single Therapy Against Multiple Respiratory Virus Infections?; available from: https:\/\/www.contagionlive.com\/view\/a-single-therapy-against-multiple-respiratory-virus-infections-. Accessed 15 Sept 2024."},{"key":"10899_CR165","doi-asserted-by":"crossref","unstructured":"Barnette KG, Gordon MS, Rodriguez D, Bird TG, Skolnick A, Schnaus M, Skarda PK, Lobo S, Sprinz E, Arabadzhiev G, et al. Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis. NEJM evidence. 2022;1(9):EVIDoa2200145.","DOI":"10.1056\/EVIDoa2200145"},{"issue":"13","key":"10899_CR166","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-22-0162","volume":"28","author":"MC Markowski","year":"2022","unstructured":"Markowski MC, Tutrone R, Pieczonka C, Barnette KG, Getzenberg RH, Rodriguez D, Steiner MS, Saltzstein DR, Eisenberger MA, Antonarakis ES. A Phase Ib\/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent. Clinical cancer research\u202f: an official journal of the American Association for Cancer Research. 2022;28(13):2789\u201395.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"10899_CR167","unstructured":"Labiotech | Emergex develops vaccine for smallpox and monkeypox; available from: https:\/\/www.labiotech.eu\/trends-news\/emergex-creates-vaccine-smallpox-monkeypox\/#:~:text=Emergex%20Vaccines%20Holding%20Limited%20has,early%20%E2%80%9Ceclipse%20phase%E2%80%9D%20antigens. Accessed 19 Oct 2024."},{"key":"10899_CR168","unstructured":"Tonix Pharmaceuticals. Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency; available from: https:\/\/ir.tonixpharma.com\/news-events\/press-releases\/detail\/1505\/tonix-pharmaceuticals-provides-update-on-the-development-of. Accessed 19 Oct 2024."},{"key":"10899_CR169","unstructured":"NCBI | NCBI Virus; available from: https:\/\/www.ncbi.nlm.nih.gov\/labs\/virus\/vssi\/#\/. Accessed 21 Sept 2024."},{"key":"10899_CR170","doi-asserted-by":"crossref","unstructured":"Yue Y, Jiang M, Zhang X, Xu J, Ye H, Zhang F, Li Z, Li Y. Mpox-AISM: AI-mediated super monitoring for mpox and like-mpox. iScience. 2024;27(5):109766.","DOI":"10.1016\/j.isci.2024.109766"},{"issue":"5","key":"10899_CR171","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s10439-023-03196-z","volume":"51","author":"K Cheng","year":"2023","unstructured":"Cheng K, He Y, Li C, Xie R, Lu Y, Gu S, Wu H. Talk with ChatGPT About the Outbreak of Mpox in 2022: Reflections and Suggestions from AI Dimensions. Ann Biomed Eng. 2023;51(5):870\u20134.","journal-title":"Ann Biomed Eng"},{"key":"10899_CR172","unstructured":"WHO| Emergencies; available from: https:\/\/www.who.int\/europe\/emergencies\/resources. Accessed 7 Oct 2024."},{"key":"10899_CR173","unstructured":"CDC| Information For Healthcare Professionals; available from: https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/index.html. Accessed 7 Oct 2024."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10899-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:02:43Z","timestamp":1744732963000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10899-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10899"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10899-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"529"}}